Current Rheumatology Reviews
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 1.2 | Q4 | 19.0% | 0.361 | Q3 | 49.8% |
| 2024 | 1.3 | Q4 | 25.9% | 0.393 | Q3 | 54.4% |
| 2023 | 1.2 | Q4 | 24.6% | 0.384 | Q3 | 56.4% |
| 2022 | 1.5 | 29.1% | 0.381 | Q3 | 57.8% | |
| 2021 | — | 34.6% | 0.426 | Q3 | 62.2% | |
| 2020 | — | — | 0.492 | Q3 | 65.7% | |
| 2019 | — | — | 0.484 | Q3 | 66.6% | |
| 2018 | — | — | 0.530 | Q3 | 67.0% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1875-6360
ISSN
1573-3971
country
AEcoverage
2006-2025